We are live on ! Find out more
DG

Delek Group Portfolio holdings

AUM $2.59B
1-Year Est. Return 1.24%
This Fund
S&P 500
This Quarter Est. Return
-16.41%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$191M
Cap. Flow
+$144M
Cap. Flow %
6.58%
Top 10 Hldgs %
23.34%
Holding
263
New
37
Increased
74
Reduced
71
Closed
47

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$36.2M
2
IFF icon
International Flavors & Fragrances
IFF
+$30.9M
3
DD icon
DuPont de Nemours
DD
+$25.5M
4
JPM icon
JPMorgan Chase
JPM
+$23.5M
5
OVV icon
Ovintiv
OVV
+$19.9M

Top Sells

Rank Stock Value
1
ORBK
Orbotech Ltd
ORBK
+$46.5M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$30.8M
3
AGN
Allergan plc
AGN
+$19.1M
4
VIRT icon
Virtu Financial
VIRT
+$17.3M
5
CPRI icon
Capri Holdings
CPRI
+$14M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.98%
2 Technology 16.06%
3 Healthcare 14.03%
4 Materials 8.78%
5 Energy 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHP icon
26
BHP
BHP
$245B
$20.4M 0.93%
461,202
+168,150
+57% +$7.05M
NVMI
27
Nova
NVMI
$11.8B
$20M 0.91%
855,069
+29,232
+4% +$692K
KRNT icon
28
Kornit Digital
KRNT
$727M
$19.9M 0.91%
1,037,028
+382,696
+58% +$7.49M
DAL icon
29
Delta Air Lines
DAL
$53.4B
$19.8M 0.9%
386,756
+71,252
+23% +$3.88M
NTR icon
30
Nutrien
NTR
$34.9B
$19.7M 0.9%
405,099
+66,925
+20% +$3.49M
PRGO icon
31
Perrigo
PRGO
$1.99B
$19.6M 0.9%
479,647
+260,486
+119% +$16.5M
CELG
32
DELISTED
Celgene Corp
CELG
$19.3M 0.88%
293,053
+89,937
+44% +$6.64M
WIX icon
33
PUT
WIX.com
WIX
$3.59B
$19M 0.87%
210,400
+12,900
+7% +$1.22M
GILD icon
34
Gilead Sciences
GILD
$185B
$19M 0.87%
293,389
+21,963
+8% +$1.54M
VRNT
35
PUT
DELISTED
Verint Systems
VRNT
$18.6M 0.85%
811,504
+664,279
+451% +$15.3M
FANG icon
36
Diamondback Energy
FANG
$56.1B
$18.6M 0.85%
194,800
+29,800
+18% +$3.33M
LEN icon
37
Lennar Class A
LEN
$20.5B
$18.1M 0.83%
465,525
+77,475
+20% +$3.16M
GILT icon
38
Gilat Satellite Networks
GILT
$798M
$18.1M 0.83%
1,925,969
-6,168
-0.3% -$56.9K
NBL
39
DELISTED
Noble Energy, Inc.
NBL
$17.6M 0.8%
928,156
+60,000
+7% +$1.54M
MRK icon
40
Merck
MRK
$369B
$17.2M 0.79%
228,576
-17,030
-7% -$1.2M
GM icon
41
General Motors
GM
$75.6B
$16.8M 0.77%
489,071
– –
AIG icon
42
American International
AIG
$40.1B
$16.5M 0.75%
407,000
– –
C icon
43
Citigroup
C
$223B
$16.2M 0.74%
300,149
+45,264
+18% +$2.87M
ALXN
44
DELISTED
Alexion Pharmaceuticals
ALXN
$16.2M 0.74%
161,933
+37,755
+30% +$4.46M
RDWR icon
45
Radware
RDWR
$1.24B
$16.1M 0.73%
688,573
+170,939
+33% +$3.94M
CRI icon
46
Carter's
CRI
$1.22B
$16M 0.73%
190,544
+20,000
+12% +$1.82M
MOS icon
47
CALL
The Mosaic Company
MOS
$7.55B
$15.7M 0.71%
536,000
+117,000
+28% +$3.85M
FL
48
DELISTED
Foot Locker
FL
$15M 0.68%
274,026
-70,000
-20% -$3.51M
AEIS icon
49
Advanced Energy
AEIS
$11.5B
$14.7M 0.67%
332,553
– –
V icon
50
Visa
V
$709B
$14.2M 0.65%
104,451
+3,387
+3% +$468K
1
2
3 4 5

Similar funds

KPAG
KLS Professional Advisors Group New York $2.15B AUM 6.46% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
LC
Lourd Capital Beverly Hills, California $1.08B AUM 8.79% 1-Year Est. Return
LIC
Lodestar Investment Counsel Chicago, Illinois $974M AUM 13.79% 1-Year Est. Return
CB
Chemical Bank Detroit, Michigan $881M AUM 4.54% 1-Year Est. Return

Delek Group's Q4 2018 Portfolio in Review

As of Q4 2018, Delek Group held 263 positions worth $2.19B, down 8% from $2.38B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Delek Group deployed $144M of net new capital in Q4 2018, opening 37 new positions and adding to 74 existing holdings. Its largest new stake was DuPont de Nemours: 177,858 shares worth $24.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $30.8M trimmed.

  • Delek Group's largest Q4 2018 buy was DuPont de Nemours: 177,858 shares worth $24.7M.
  • Delek Group added most to Teva Pharmaceuticals in Q4 2018, an estimated $36.2M increase.
  • Delek Group's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $30.8M.
  • Delek Group fully exited Orbotech Ltd in Q4 2018, selling an estimated $46.5M.
  • Delek Group's ten largest holdings make up 23% of its $2.19B portfolio in Q4 2018.
  • Delek Group opened 37 new positions and closed 47 in Q4 2018.
  • Delek Group's portfolio value fell 8% quarter-over-quarter to $2.19B.

Based on Delek Group's 13F filing for Q4 2018, filed 14 Feb 2019.